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Abstract
Background:  Reducing maternal mortality and morbidity are among the key international
development goals. A prerequisite for monitoring the progress towards attainment of these goals
is accurate assessment of the levels of mortality and morbidity. In order to contribute to mapping
the global burden of reproductive ill-health, we are conducting a systematic review of incidence and
prevalence of maternal mortality and morbidity.
Methods:  We followed the standard methodology for systematic reviews. We prepared a
protocol and a form for data extraction that identify key characteristics on study and reporting
quality. An extensive search was conducted for the years 1997–2002 including electronic and hand
searching.
Results: We screened the titles and abstracts of about 65,000 citations identified through 11
electronic databases as well as various other sources. Four thousand six hundred and twenty-six
full-text reports were critically appraised and 2443 are included in the review so far. Approximately
one third of the studies were conducted in Asia and Africa. The reporting quality was generally low
with definitions for conditions and the diagnostic methods often not reported.
Conclusions: There are unique challenges and issues regarding the search, critical appraisal and
summarizing epidemiological data in this systematic review of prevalence/incidence studies. More
methodological studies and discussion to advance the field will be useful. Considerable efforts
including leadership, consensus building and resources are required to improve the standards of
monitoring burden of disease.
Background
Levels of maternal mortality and morbidity tell us about
the risk attributable to pregnancy and childbirth as well as
the performance of health systems in terms of access to
health care and the quality of care provided. However,
accurate assessment of these indicators has been problem-
atic. The World Health Organization (WHO) has devel-
oped estimates of maternal mortality [1,2], anaemia
during pregnancy, low birth weight and unsafe abortion
at national, regional and global levels using modelling
techniques. The lack of good quality data for many coun-
tries and different methodologies used to estimate levels
of mortality complicate monitoring of the trends and
comparisons between countries [3,4].
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Although considerable amounts of facility-based data on
maternal morbidity are generated, these may not reflect
the actual health status of women in the whole commu-
nity or area. Population-based data on the status of
women's health are more useful and needed, yet scarce.
Even when available, the challenge remains as to how to
compile and summarize the data and thus map the bur-
den of reproductive ill-health. A logical approach is to
extend the concept of systematic reviews from ran-
domised controlled trials to observational data [5-7].
For more than a decade, systematic reviews of randomised
controlled trials (RCTs) have been used increasingly to
evaluate the effectiveness of various health care interven-
tions. The Cochrane Library as of 2004 includes more
than 3000 systematic reviews [8]. Considerable experi-
ence of methodological issues such as literature search,
critical appraisal of identified studies and methods for
summarising data has been gained and tools have been
developed for the reviews and meta-analysis of RCTs [8].
However, systematic reviews of observational studies are
rather rare and the relevant experience is limited [6]. Most
of the work in this area relates to questions for which
RCTs are difficult, impossible or unethical to conduct (e.g.
testing aetiological hypothesis, less common adverse
effects in drugs) [9]. Methodological issues with regard to
inclusion of studies with different designs, population
and setting characteristics, and statistical methods to com-
bine the data are evolving and need to be improved
[6,10].
With these considerations, we are conducting a systematic
review of prevalence/incidence of maternal mortality and
morbidities from 1997 to 2002. The primary objective is
to contribute to mapping the global burden of reproduc-
tive ill-health. The review will provide a comprehensive,
standardized and reliable tabulation of available data on
the incidence/prevalence of maternal morbidity and mor-
tality, and case-fatality rates for maternal morbid condi-
tions. The review will also assist us in identifying the most
commonly used set of definitions for some pregnancy
related conditions, in testing a set of critical appraisal and
data-extraction instruments that can be used in future
reviews of observational studies, and in guiding future
research in this field.
We prepared a protocol [11] and a form for data extrac-
tion (See Additional file 1) which were both peer-
reviewed. In this manuscript, we present our experience
with the methodological, technical and practical chal-
lenges encountered in conducting the review.
Methods
Criteria for considering studies
Types of studies
For maternal morbidity, any study type providing preva-
lence, incidence or case-fatality rates for specified mater-
nal morbid conditions is considered. These include
mainly cross-sectional and cohort studies, clinical trials,
and incidence/prevalence surveys. Case-control studies
are included if the cases selected correspond to all cases in
a given population where the denominator is also known.
Intervention and control arms of controlled trials are
treated separately.
For maternal mortality, studies providing estimates of
maternal mortality levels derived from direct counting, or
from special surveys are considered for inclusion. Esti-
mates derived from modelling of other variables or
extrapolations from other populations are excluded.
Types of participants
Women either pregnant or within one year of termination
of pregnancy.
Types of outcomes
Maternal mortality and morbid conditions defined
according to the International Classification of Diseases,
10th revision (ICD-10) [12].
Studies are ineligible if any of the following apply: (i) data
collection dates are not reported, (ii) data are collected
only before 1990, (iii) part of the data is collected before
1980 and disaggregation by year is not possible (in order
to exclude data before 1990), (iv) number of study partic-
ipants is less than 200 (this criterion imposed arbitrarily),
(v) the study design is case-control and incidence/preva-
lence estimates from the defined population cannot be
calculated, (vi) the methodology is not described.
Search strategy for identification of studies
We searched for published and unpublished studies
reported between 1997 and 2002 in any language. The
decision to start from 1997 was arbitrary and based on the
concept of reviewing recent data.
The sources searched to identify studies included elec-
tronic databases (Medline, Popline, EMBASE, LILACS,
CAB Abstracts, SocioFile, CINAHL, Econlit, BIOSIS, PAIS
International, Index Medicus for the Eastern Mediterra-
nean Region (EMRO) – on-line database of WHO/
EMRO); web pages from Ministries of Health for official
information and other potentially relevant internet
sources (e.g. reproductive health gateway, development
gateway, dissertation abstracts, Google). Additional file 2
includes detailed strategy for electronic search.BMC Medical Research Methodology 2004, 4:16 http://www.biomedcentral.com/1471-2288/4/16
Page 3 of 8
(page number not for citation purposes)
In addition, we checked reference lists of retrieved articles,
proceedings and abstract books of related congresses. We
hand searched journals at WHO headquarters' library that
are not indexed in electronic databases and countries' sta-
tistical reports held at the WHO library. We contacted
country focal experts such as WHO representatives and
staff from collaborating centres, non-governmental
organizations (NGOs), and other organizations known to
be active in the field.
A WHO specialised librarian and the trial search coordina-
tor of the Cochrane Collaboration Pregnancy and Child-
birth Group developed the search strategy for each of the
electronic databases according to their specific subject
headings or searching structure in collaboration with the
reviewers. We tested the search strategy for citations from
1997, modified the strategy and ran it for the whole
period. We used Reference Manager® software [13] to keep
track of the citations identified. We downloaded the cita-
tions identified in electronic searches into Reference Man-
ager®  and entered those retrieved from other sources
manually (e.g. hand searching, reference lists). We deleted
duplicates and assigned a unique identification number
for each citation.
Screening and data-extraction form
Initially, we evaluated all identified citations on the basis
of titles and/or abstracts against the eligibility criteria.
Those deemed to be irrelevant were excluded and reasons
for exclusion noted. A list of excluded reports and the rea-
sons for exclusion are available from the authors upon
request. When the information provided by titles/
abstracts was insufficient to decide on inclusion/exclu-
sion, or the titles/abstracts were relevant to the project, we
retrieved and evaluated the full-text. As of January 2004,
we screened titles/abstracts of a total of 64,586 citations
from years 1997 to 2002. Among these, 59,960 were
excluded and we retrieved full-text reports of the remain-
ing 4626 (Figure 1).
We completed a specially designed screening form for
each full-text evaluated report. This form was used to col-
lect information on whether the report was included or
not and if excluded, the reason for this. For reports meet-
ing more than one exclusion criterion, only one reason –
following the order on the screening form – was reported
as the reason for exclusion. We extracted data from the
included studies using a specifically designed data extrac-
tion form (See Additional file 1). This form includes 48
questions distributed in five modules. Modules were
designed to collect information on (i) the general charac-
teristics of the study such as design, population, setting,
(ii) prevalence/incidence of maternal morbid conditions,
(iii) maternal mortality, (iv) quality assessment of mor-
bidity reports and (v) quality assessment of studies report-
ing maternal mortality. We also developed a manual for
providing definitions and instructions on how to extract
the data (available upon request from the authors). We
tested both screening and data-extraction forms for a
group of studies of different designs and revised prior to
use.
Agreement between the reviewers in screening and data 
extraction
Two reviewers independently screened titles/abstracts
from a sample of citations identified through the elec-
tronic search. In order to estimate the level of disagree-
ment between two reviewers when including studies in
the systematic review within 2.5% of the true value, a total
of 560 studies needed to be classified. This sample size
assumes a 95% confidence interval and that the level of
disagreement between the two reviewers will not exceed
10% [14]. The percentage of agreement was 88.9% (95%
CI 86.0% to 91.4%). The inter-observer agreement
beyond chance was calculated using the Kappa statistics
and found to be 0.60 (95% CI 0.52 to 0.69). This value
corresponds to moderate to substantial agreement
between the reviewers [15].
Two reviewers independently assessed full-texts of 50 arti-
cles for inclusion in the review following the initial
screening process and completed the data extraction
forms for those that were eligible for inclusion. The
reviewers then compared results and disagreements were
resolved following discussion. The decision on the
number of this sample was agreed on arbitrarily at the
beginning and deemed to be sufficient following the dis-
cussions on the completed forms.
Data processing
We categorised variables of interest and developed codes
for responses to open-ended questions to facilitate data
entry and statistical analysis. Initially, we classified mor-
bidities according to the ICD-10 [12], using the classifica-
tions described mainly in chapter XV, which addresses
pregnancy, childbirth and postpartum conditions. We
assigned unique codes to some conditions (e.g.
obstructed labour) that are classified with different codes
in ICD-10 according to etiological distinctions. (See Addi-
tional file 3). These changes were made to facilitate the
coding of the conditions during the data extraction proc-
ess since definitions do not generally include etiological
distinctions in incidence/prevalence studies of maternal
conditions.
We preferred to extract raw data but where only percent-
ages or rates were available, we also included these. Data
presented in graphs and figures were used only if numbers
(or percentages) were described in the text or labelled in
the graph. Such data were not used if extrapolation wasBMC Medical Research Methodology 2004, 4:16 http://www.biomedcentral.com/1471-2288/4/16
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required. Once data extraction was completed, data were
reviewed to identify duplicate data, for example the same
results published in more than one journal or published
papers whose unpublished drafts had been identified pre-
viously. Data were manually double entered in a specific
database and processed with SAS software®.
Appraising methodological quality of primary studies
We excluded studies that did not state the methodology
used to obtain data. For quality appraisal, we extracted
information on (i) study design, sampling method,
sources of data and completeness of follow-up or records
and, (ii) reported definitions and diagnostic procedures
regarding outcome measures.
The evaluation of methodological and reporting quality
was used to assess the reliability and accuracy of the data
as objectively as possible. For example, the selection crite-
ria and certain characteristics of participants such as eco-
nomic status, ethnicity, age group or health status allow
assessment of the external validity or generalisability of
results in addition to presentation of stratified analysis for
Flow diagram of the process of identifying and including references for the systematic review Figure 1
Flow diagram of the process of identifying and including references for the systematic review.
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different categories. Likewise, information on the propor-
tions and characteristics of losses to follow-up, non-
responders or those not included in the final analysis after
having been initially selected for the study was used to
assess the internal validity of a study.
Furthermore, we assumed that the presence of definitions
of conditions and description of diagnostic methods or
procedures could be regarded as an indication of higher
quality. For studies which reported maternal mortality, in
addition to categorising definitions of maternal mortality,
we recorded information about special efforts to capture
all maternal deaths and the method to confirm deaths as
maternal (e.g. confidential enquiry, verbal autopsy) as
indication of higher quality.
Results
We identified and screened about 65,000 different cita-
tions for the period 1997–2002. As of January 2004, 4626
citations were identified as potentially eligible for full-text
evaluation, 2443 of which were included and 1988
excluded. The remaining 195 are in the process of retrieval
and evaluation (Figure 1). Citations were mostly excluded
because of no relevant data (57%), sample size less than
200 (16%) and no dates of data collection period (11%).
The number of included studies for which data extraction
and entry is complete is 2204. The distribution of these
studies according to their designs, selected characteristics
of the population and settings are summarised in Table 1.
Most studies use a cross sectional design (69.5%). The
study population is urban in 17% of the studies, rural in
6.7%, mixed in 43.6% and unknown in 32.7%. Nearly
two-thirds of the data is facility based while most of the
rest is either nationally or regionally representative.
Almost half of the studies are from Europe and North
America and one-third are from Asia and Africa (Table 2).
Similarly, half of the studies are conducted in 43 industr-
ialised countries while the remainder are from 95 less
developed and 46 least developed countries (Table 3).
The data were disaggregated by study periods, age groups,
ethnic groups, settings and interventions used (i.e. differ-
ent arms of RCTs) where possible and entered in the data-
base as separate data sets. From 2204 included studies, we
obtained 3805 data sets most of which include preva-
lence/incidence data on more than one morbidity. Mor-
bidities of interest in our review were reported 5933 times
in these data sets. Table 4 presents the distribution of
reported morbidities and shows that hypertensive disor-
ders of pregnancy and stillbirth were most frequently
reported (14.9 % and 13.9%, respectively).
A preliminary assessment of the reporting quality of stud-
ies shows that the quality is generally low. For example,
for hypertensive disorders, about 50% included defini-
tions and only 10% described the diagnostic procedure.
More than half of the studies of maternal mortality did
not report the definition used for maternal death, and
two-thirds did not use any method to confirm the death
as maternal. Similarly, less than 20% attempted to capture
all maternal deaths among the population studied.
Discussion
In this paper, we present our initial experience with con-
ducting this large-scale systematic review of observational
studies. We discuss methodological challenges as well as
barriers encountered at both technical and logistic levels.
We present preliminary results on the descriptive charac-
teristics of the data set and expect to generate more discus-
sion and empirical research in this area.
One of the main strengths of this systematic review is the
comprehensive search strategy including multiple elec-
tronic databases. This search strategy yielded a large
number of disparate records. This is partly due to the fact
that searching according to study type is possible only for
controlled trials. Initial screening by titles and abstracts to
select relevant studies reduced the number of potentially
relevant reports to a reasonably manageable level. How-
ever, it was not always straightforward to judge relevance
from abstracts and this has been a tedious and time-con-
suming process.
Identification of duplicate records has been another time-
consuming activity. Different databases use different for-
mats for indexing titles and/or authors. For example,
authors of articles written in Spanish tend to present two
Table 1: Selected characteristics of included studies.
Number (%)
Study design
Cross-sectional 1532 (69.5)
Cohort 274 (12.4)
Incidence/prevalence survey 220 (10.0)
Controlled trial 52 (2.4)
Census 22 (1.0)
Others 104 (4.7)
Population characteristics
Urban 375 (17.0)
Rural 147 (6.7)
Mixed 962 (43.6)
Unknown 720 (32.7)
Characteristics of the setting
National 414 (18.8)
Provincial 288 (13.1)
City-based 93 (4.2)
Other 39 (1.8)
Health facility-based 1370 (62.1)
Overall 2204BMC Medical Research Methodology 2004, 4:16 http://www.biomedcentral.com/1471-2288/4/16
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surnames. The first surname may not be recognised cor-
rectly or surname and first name are not always differenti-
ated [16,17]. This lack of uniformity in formatting of
citations across databases causes several different record-
ings of the same article if indexed in more than one
database. We experienced an exhaustive process of man-
ual searching and deleting of duplicate records to address
this issue.
Although efforts to develop methodologies for searching
for and summarising data from observational studies
exist, these focus largely on effects of health care interven-
tions that are difficult or impossible to evaluate through
RCTs [18]. The associations between risk factors and dis-
ease occurrence, evaluation of diagnostic and screening
tests or prognostic variables are other areas that require
reviews of observational studies and pose particular meth-
odological challenges [9].
The specific issues relating to analysis of data from system-
atic reviews of incidence/prevalence studies need to be
systematically explored in order to guide developments in
this field. Evaluating the comparability in terms of design,
population and setting, and summarizing results pose
specific methodological challenges.
A great deal of variation in the incidence/prevalence of
maternal conditions between studies has been shown to
be related to variations in definitions [19-21]. In addition,
for many conditions studied, we identified that a variety
of diagnostic tests with different levels of precision were
used. We extracted detailed information on such charac-
teristics of the studies in order to explore the contribution
of these factors to the heterogeneity of the results. We
envisage providing a tabulation of the most commonly
used definitions and diagnostic procedures for each con-
dition. In a second step, we will examine why the 'most
recommended' or 'official' definition or diagnostic proce-
dure is or is not used and how this affects the outcomes.
This could provide a background for initiatives to stand-
ardize the definitions and improve the accuracy of
measurements.
Another issue of concern is the general poor reporting
quality of the studies. Characteristics of the populations
and/or settings, definitions of outcomes and diagnostic
procedures are not systematically described in the reports.
This could limit the comparability of the studies and util-
ity of some data extracted.
An important challenge for systematic reviews on burden
of disease is to identify all available data from less devel-
oped countries [22]. Studies from these countries are
likely to be published in non-indexed and non-English
journals. The amount of research conducted in those
countries may also be less considering the difficulties of
securing funds for research. Nevertheless, we think that
the final data set will include substantial amount of data
from developing countries.
Table 2: Regional distribution of included studies and reports of maternal morbidity and mortality [24].
Regions N reporting only morbidity N reporting only mortality N reporting morbidity and 
mortality
Total
Europe 482 39 34 555
Asia 374 68 30 472
North America 405 28 4 437
Africa 201 102 70 373
Latin America and the 
Caribbean
156 85 23 264
Australia/Oceania 60 5 1 66
Other (e.g. multicountry) 26 6 5 37
Overall 1704 333 167 2204
Table 3: Distribution of included studies according to the development status of the country where the study was conducted [24].
Country type N reporting only morbidity N reporting only mortality N reporting morbidity and 
mortality
Total
Industrialised (N = 43) 971 75 39 1085
Less developed (N = 95) 584 183 87 854
Least developed (N = 46) 123 69 36 228
Other (e.g. multicountry) 26 6 5 37
Overall 1704 333 167 2204BMC Medical Research Methodology 2004, 4:16 http://www.biomedcentral.com/1471-2288/4/16
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The first decade of this new millennium will be a test of
our capability and ability to cope with the ever-increasing
amounts of information produced. To analyse all availa-
ble information in a reliable way, we need systematic
reviews that include comprehensive searches, critical eval-
uation of studies and advances in statistical and other
(searching, appraisal) methodologies. Considering the
fact that it took almost 20 years to achieve satisfactory
standards of synthesising the research into the effects of
health care interventions, it is clear from our initial work
that similar efforts, including leadership, consensus build-
ing and resources are required to improve the standards of
monitoring the burden of disease.
The conceptualisation of this review, completion of a pro-
tocol and actual conduct has taken three years with several
staff members involved. Full results will be available at the
end of 2004. Although complex and time-consuming this
systematic review and others on this issue will contribute
to the Millennium Project [23] in several ways. Firstly,
quantifying the burden not only through modelling
approaches but also through in depth analyses of empiri-
cal studies will improve our understanding of the magni-
tude of the problem. Secondly, by identifying the gaps in
the methodology and reporting, future research could be
designed more rigorously.
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